drugset / Trial / NCT00176748
Treatment for Patients With Metastatic Thyroid Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is being done to find out the good and bad effects of an investigational drug that is not approved for sale, called AG-013736. Tumors need blood vessels in order to continue to grow, and AG-013736 is thought to work by playing a role in preventing new blood vessels from growing. We want to see if AG-013736 has any effect on your disease by making your tumor smaller and if so, for how long. We also want to test the safety \[the effect on your body\] of AG-013736 and to measure the amount of AG-013736 that gets into your blood. AG-013736 has been given to over 140 patients with cancer on other studies.
Timeline
- Start
- 2005-07
- Primary completion
- 2006-08
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AG 6013736 | Unknown | 5 mg | Oral |